Loratadine

Product NDC
70010-162
Type
HUMAN OTC DRUG
Nonproprietary name
Loratadine
Dosage form
TABLET
Route
ORAL
Labeler
Granules Pharmaceuticals Inc.
Application
ANDA210722
Marketing category
ANDA
Substance
LORATADINE
Current FDA listing
Yes

Related Records

Packages

Package NDCDescriptionMarketing startMarketing endSampleStatus
70010-162-01100 TABLET in 1 BOTTLE (70010-162-01) 20211117NoHistorical
70010-162-0330 TABLET in 1 BOTTLE (70010-162-03) 20220501NoHistorical
70010-162-34300 TABLET in 1 BOTTLE (70010-162-34) 20220501NoHistorical

Related DailyMed Labels

Set IDTitleManufacturerEffective dateTypeVersion
16f00a3a-0777-f70c-e063-6294a90a71c9Loratadine Tablets, 10 mgNuCare Pharmaceuticals,Inc.2026-04-06HUMAN OTC DRUG LABEL3
2bc586e4-5297-44cf-e063-6294a90a531dLoratadine Tablets, 10 mgST. MARY'S MEDICAL PARK PHARMACY2025-12-08HUMAN OTC DRUG LABEL2
c6144a33-6b33-4aca-86e5-a3f688b8b317Loratadine Tablets, 10 mgPreferred Pharmaceuticals Inc.2025-07-24HUMAN OTC DRUG LABEL2
0d74af21-3ef7-418b-a2ef-78737b0af288Loratadine Tablets, 10 mgBryant Ranch Prepack2025-06-13HUMAN PRESCRIPTION DRUG LABEL2
a5d54183-06a9-4ae1-93b9-e9a2e03ad42bLoratadine Tablets, 10 mgBryant Ranch Prepack2025-06-13HUMAN OTC DRUG LABEL2
d15add22-bc2d-9730-e053-2a95a90acd3fLoratadine Tablets, 10 mgGranules Pharmaceuticals Inc.2025-05-05HUMAN OTC DRUG LABEL5